Fresenius SE & Co. KGaA



 


WELCOME TO FRESENIUS SE

Fresenius - the health care group

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.

The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius KabiFresenius Helios and Fresenius Vamed.


Latest news

29.07.2015
Accelerating sales and earnings growth in Q2 – Fresenius raises Group earnings guidance for 2015
Ulf Mark Schneider, CEO of Fresenius, said: “Our strong growth trend continues in all four business segments. In times of economic volatility, our broad geographic presence and well-diversified business provide reliable growth and continue to contribute to Fresenius’ overall success. We are highly confident of our Company’s growth prospects and raise our Group earnings guidance.” >>>
29.07.2015
Fresenius Medical Care reports second quarter 2015 results and confirms guidance for full year 2015
Rice Powell, chief executive officer of Fresenius Medical Care stated: “Our second quarter 2015 results showed a positive underlying performance. We are pleased with our revenue and earnings growth considering the negative currency impact on our International operations in the second quarter. [...]" >>>
20.05.2015
Fresenius SE & Co. KGaA Annual General Meeting: 2015 guidance confirmed, 22nd consecutive dividend increase approved
Fresenius expects to set new sales and earnings records in 2015. Ulf Mark Schneider, CEO of Fresenius, confirmed the company’s growth targets at the Annual General Meeting in Frankfurt today. >>>
19.05.2015
Fresenius Medical Care confirms growth targets – Shareholders approve 18th consecutive dividend increase
Fresenius Medical Care is aiming to increase sales and earnings in the coming years. At today’s Annual General Meeting in Frankfurt, chief executive officer Rice Powell confirmed the company’s growth targets for 2015 and beyond. >>>
04.05.2015
Fresenius Medical Care introduces multiFiltratePRO, a new therapy system for acute dialysis
Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, has launched multiFiltratePRO, a therapy system for continuous renal replacement therapy (CRRT), for the treatment of acute kidney failure in critically ill patients at intensive care units. >>>